Medical Cannabis for Chronic Back Pain — Switzerland 2026

Chronic back pain is the most common pain diagnosis in Switzerland. Cannabis as an opioid-sparing option — 50 CHF for members instead of 190.

1.5M Swiss suffer chronic back pain. Standard: NSAIDs, physio, possibly opioids (addiction risk). Cannabis (THC/CBD 1:1) reduces pain scores by 25–40 % and enables opioid reduction (Boehnke 2019, Aviram 2020). Members: 50 CHF instead of 190.

What the studies show

Boehnke 2019 (J Pain): 79 % of patients reduce opioids after 6 months of cannabis therapy.

Aviram 2020 (Israeli registry, n=2,736): 60 % pain reduction ≥30 %, significant sleep & function improvement.

Preparations & dosing

THC/CBD 1:1 oil (e.g. 10/10 mg/ml): 2–5 drops evenings, slow titration.

Full-spectrum CBD 50 mg twice daily as day base, THC oil evenings for night pain.

Save as a CannabisClub member

Pain medicine consultation: 190–260 CHF. Members: 50 CHF flat, telemedicine. Registration free.

FAQ

Does cannabis replace my physio?

No. Multimodal therapy remains standard — cannabis reduces pain, active therapy remains central.

What does membership save?

50 CHF instead of 190 CHF per consultation. Registration free.

Does insurance cover it?

For documented chronic back pain + prior treatments: art. 71a request possible, not guaranteed.

Cannabis for Back Pain — Chronic Lumbago Switzerland 2026 (Members 50 CHF)